These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 7756472

  • 1. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Opravil M, Hirschel B, Lazzarin A, Heald A, Pechère M, Rüttimann S, Iten A, von Overbeck J, Oertle D, Praz G.
    Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472
    [Abstract] [Full Text] [Related]

  • 2. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, Gaudebout C, Certain A, Boué F, Bouvet E.
    N Engl J Med; 1993 May 27; 328(21):1514-20. PubMed ID: 8479488
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Torres RA, Barr M, Thorn M, Gregory G, Kiely S, Chanin E, Carlo C, Martin M, Thornton J.
    Am J Med; 1993 Dec 27; 95(6):573-83. PubMed ID: 8018144
    [Abstract] [Full Text] [Related]

  • 4. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J, Zamora L, Gatell JM, Miró JM, Vernet E, Valls ME, Soriano E, SanMiguel JG.
    AIDS; 1993 Jan 27; 7(1):59-64. PubMed ID: 8442918
    [Abstract] [Full Text] [Related]

  • 5. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Tocchetti A, Tambini R, Allegro A, Longoni E, Rinaldi E.
    AIDS; 1994 Feb 27; 8(2):272-4. PubMed ID: 8043236
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine.
    Köppen S, Grünewald T, Jautzke G, Gottschalk J, Pohle HD, Ruf B.
    Clin Investig; 1992 Jun 27; 70(6):508-12. PubMed ID: 1356529
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC, Griffith L, Guyatt GH, Opravil M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun 01; 15(2):104-14. PubMed ID: 9241108
    [Abstract] [Full Text] [Related]

  • 8. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A, Murri R, Ammassari A, De Luca A, Linzalone A, Cingolani A, Damiano F, Maiuro G, Vecchiet J, Scoppettuolo G.
    AIDS; 1995 Dec 01; 9(12):1343-50. PubMed ID: 8605054
    [Abstract] [Full Text] [Related]

  • 9. Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
    Opravil M, Pechère M, Lazzarin A, Heald A, Rüttimann S, Iten A, Furrer H, Oertle D, Praz G, Vuitton DA.
    Clin Infect Dis; 1995 Feb 01; 20(2):244-9. PubMed ID: 7742423
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Wünsche T, Grünewald T, Schürmann M, Grobusch M, Vallée M, Ruf B, Suttorp N.
    Eur J Clin Microbiol Infect Dis; 2002 May 01; 21(5):353-61. PubMed ID: 12072919
    [Abstract] [Full Text] [Related]

  • 11. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
    Podzamczer D, Miró JM, Bolao F, Gatell JM, Cosín J, Sirera G, Domingo P, Laguna F, Santamaría J, Verdejo J.
    Ann Intern Med; 1995 Aug 01; 123(3):175-80. PubMed ID: 7598298
    [Abstract] [Full Text] [Related]

  • 12. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D, Salazar A, Jiménez J, Consiglio E, Santín M, Casanova A, Rufí G, Gudiol F.
    Ann Intern Med; 1995 May 15; 122(10):755-61. PubMed ID: 7717598
    [Abstract] [Full Text] [Related]

  • 13. Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Opravil M, Joos B, Lüthy R.
    Antimicrob Agents Chemother; 1994 May 15; 38(5):1197-9. PubMed ID: 8067765
    [Abstract] [Full Text] [Related]

  • 14. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Grünewald T, Behnsch M, Grobusch M, Vallée M, Wünsche T, Ruf B, Suttorp N.
    J Infect; 2001 Jan 15; 42(1):8-15. PubMed ID: 11243747
    [Abstract] [Full Text] [Related]

  • 15. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
    Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R, Cooper DA.
    Ann Intern Med; 1992 Jul 15; 117(2):106-11. PubMed ID: 1351371
    [Abstract] [Full Text] [Related]

  • 16. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
    Bossi P, Caumes E, Astagneau P, Li TS, Paris L, Mengual X, Katlama C, Bricaire F.
    Rev Med Interne; 1998 May 15; 19(5):313-7. PubMed ID: 9775164
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J.
    N Engl J Med; 1995 Mar 16; 332(11):693-9. PubMed ID: 7854375
    [Abstract] [Full Text] [Related]

  • 18. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC, Rimland D.
    Pharmacotherapy; 1996 Mar 16; 16(6):1030-8. PubMed ID: 8947975
    [Abstract] [Full Text] [Related]

  • 19. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
    Rizzardi GP, Lazzarin A, Musicco M, Frigerio D, Maillard M, Lucchini M, Moroni M.
    J Infect; 1996 Mar 16; 32(2):123-31. PubMed ID: 8708369
    [Abstract] [Full Text] [Related]

  • 20. Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection.
    Dorrell L, McCallum AK, Snow MH, Ong EL.
    AIDS Patient Care; 1995 Oct 16; 9(5):224-8. PubMed ID: 11361401
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.